Industry

VIENNA–(BUSINESS WIRE)–OncoOne, a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, today announced the appointment of three new members to its scientific advisory board to accelerate the clinical development of the company’s oxidized macrophage migration inhibitory factor (oxMIF)-targeting pipeline. oxMIF is the disease-related and druggable isoform of the macrophage migration inhibitory … [Read more…]

Funding Consist of Series A Financing from Novalis Biotech and Crédit Agricole des Savoie, as well as support from Bpifrance GRENOBLE, France–(BUSINESS WIRE)–Carroucell, the microcarrier supplier for cell culture in bioreactor, announced today that it has raised a total of €1.5 million. The funding includes the closing of a Series A financing, led by the … [Read more…]

EINDHOVEN, Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that management will participate in the following upcoming investor events in September: KBC Securities Virtual Life Sciences Conference September 16, 2022 Dave Marver, … [Read more…]

Research highlights consumer-facing companies need to respond to redefined consumer priorities NEW YORK–(BUSINESS WIRE)–Despite financial uncertainty, consumers are not willing to reduce the amount they spend on health and well-being, according to the latest in a series of consumer surveys that Accenture (NYSE: ACN) has been conducting to test the pulse of consumer outlook and … [Read more…]

Developed a unique current waveform that enhances the saltiness of low-sodium foods by approximately 1.5 times. Spoon and bowl-shaped “Electric Salt” devices with this current waveform have been developed. Joint demonstration experiment with two companies proposing healthy eating started in September. Aiming to launch the device in Japan in 2023.   TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, … [Read more…]

ROSENBERG, Texas–(BUSINESS WIRE)–Seatex, LLC (“Seatex”, or the “Company”), a leading specialty chemical manufacturer and formulator, is pleased to announce the acquisition of ChemQuest Chemicals, LLC (“ChemQuest”), a custom chemical manufacturer headquartered in Pasadena, Texas. For over twenty-five years, ChemQuest has provided custom toll manufacturing services to customers globally, with expertise in complex blending and reactionary … [Read more…]

— Approval Marks Kite’s Fourth Indication in Europe for its Two Cell Therapies and First in Leukemia — — Overall Complete Remission of 71% and a Median Overall Survival of More Than Two Years for All Patients and Almost Four Years for Responders Demonstrated in ZUMA-3 Trial– SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite, a Gilead Company (Nasdaq: … [Read more…]

The seasoned executive will support and further the biotech company’s cell therapeutics growth by facilitating company expansion, capitalization and strategic development. DENVER–(BUSINESS WIRE)–$GLTI #biotech–James Johnston, an innovative executive with extensive financial and strategic experience with global organizations, has joined the board of directors of Greyledge Technologies, Inc. (“Greyledge” or “the Company”). He has served as … [Read more…]

PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that management will participate in investor meetings at the Citi 17th Annual BioPharma Conference on September 7 – 8, 2022 in Boston, Massachusetts. About Reata Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) will host a virtual Investor Update on Thursday, September 15, 2022. The Investor Update will include presentations by company leaders focusing on Humana’s strategic direction, operational and financial progress as well as expectations for future performance. Presentations will begin at 8:30 a.m. Eastern. The Investor Update webcast and virtual … [Read more…]